Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 51 device-driven procedures, CMS 2024
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Decompression & minimally invasive spine | 114 | 4,105−5.1%/yr | −5.1%/yr | 3.61.2× | 8% | 4,010 in 2030−0.4%/yr |
| Lumbar fusion | 90 | 3,677−2.1%/yr | −2.1%/yr | 3.21.2× | 1% | 4,120 in 2030+1.9%/yr |
| Cervical fusion & disc arthroplasty | 25 | 1,738−4.6%/yr | −4.6%/yr | 1.51.1× | 5% | 1,920 in 2030+1.7%/yr |
| Kyphoplasty & vertebroplasty | 15 | 1,537−7.3%/yr | −7.3%/yr | 1.41.0× | 1% | 1,360 in 2030−2.1%/yr |
| SI joint fusion | 7 | 367+22%/yr | +22%/yr | 0.31.6× | 11% | 610 in 2030+8.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 637 | 116,086−1.2%/yr | −1.2%/yr | 99.71.3× | 32% | 124,800 in 2030+1.2%/yr |
| Skin substitutes & wound grafts | 39 | 12,139+7.6%/yr | +7.6%/yr | 6.30.8× | 47% | 15,800 in 2030+4.5%/yr |
| Bone graft & orthobiologics | 17 | 623−12%/yr | −12%/yr | 0.50.8× | 1% | 580 in 2030−1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 179 | 10,830−5.3%/yr | −5.3%/yr | 9.31.1× | 43% | 11,600 in 2030+1.2%/yr |
| Peripheral nerve stimulation & intrathecal pumps | 26 | 1,792+4.2%/yr | +4.2%/yr | 1.51.5× | 20% | 2,660 in 2030+6.8%/yr |
| Spinal cord & DRG stimulation | 22 | 900−1.9%/yr | −1.9%/yr | 0.71.1× | 32% | 1,040 in 2030+2.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Dialysis access | 46 | 4,014−15%/yr | −15%/yr | 3.80.8× | 68% | 3,930 in 2030−0.4%/yr |
| Peripheral arterial intervention | 26 | 3,751−11%/yr | −11%/yr | 3.20.7× | 4% | 3,700 in 2030−0.2%/yr |
| Superficial venous ablation | 47 | 3,475−3.2%/yr | −3.2%/yr | 3.00.9× | 79% | 4,520 in 2030+4.5%/yr |
| Thrombectomy, IVC filters & venous stents | 6 | 1,351−4.1%/yr | −4.1%/yr | 1.20.8× | 0% | 1,470 in 2030+1.4%/yr |
| Carotid revascularization | 18 | 1,238−6.8%/yr | −6.8%/yr | 1.10.9× | 0% | 1,200 in 2030−0.6%/yr |
| Aortic endografts (EVAR/TEVAR) | 3 | 615−5.9%/yr | −5.9%/yr | 0.61.2× | 0% | 460 in 2030−4.8%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 75 | 6,844−3.3%/yr | −3.3%/yr | 6.61.1× | 5% | 7,430 in 2030+1.4%/yr |
| Cholecystectomy & appendectomy | 70 | 4,777−4.3%/yr | −4.3%/yr | 4.51.0× | 1% | 5,070 in 2030+1%/yr |
| Colorectal resection | 8 | 1,916−5.8%/yr | −5.8%/yr | 1.81.0× | 0% | 2,040 in 2030+1.1%/yr |
| Antireflux & hiatal hernia surgery | 13 | 867−1.9%/yr | −1.9%/yr | 0.81.0× | 0% | 880 in 2030+0.2%/yr |
| Breast reconstruction | 1 | 469−2.5%/yr | −2.5%/yr | 0.41.0× | 0% | 380 in 2030−3.5%/yr |
| Bariatric surgery | 0 | 199−17%/yr | −17%/yr | 0.20.9× | 0% | 130 in 2030−6.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Kidney stone management | 150 | 6,970−0.5%/yr | −0.5%/yr | 6.41.2× | 12% | 7,740 in 2030+1.8%/yr |
| BPH procedures | 84 | 6,150−1.9%/yr | −1.9%/yr | 5.51.3× | 21% | 5,630 in 2030−1.5%/yr |
| Hysterectomy, hysteroscopy & ablation | 26 | 3,124−0.8%/yr | −0.8%/yr | 3.11.1× | 7% | 3,530 in 2030+2%/yr |
| Incontinence, prolapse & sacral neuromodulation | 37 | 2,896−3.5%/yr | −3.5%/yr | 2.61.2× | 7% | 2,970 in 2030+0.4%/yr |
| Prostatectomy & nephrectomy | 19 | 1,532−1.5%/yr | −1.5%/yr | 1.51.1× | 0% | 1,790 in 2030+2.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 27 | 3,442−2.1%/yr | −2.1%/yr | 3.20.9× | 67% | 3,940 in 2030+2.3%/yr |
| Ear tubes & middle ear surgery | 5 | 613−2.7%/yr | −2.7%/yr | 0.61.9× | 24% | 470 in 2030−4.4%/yr |
| Sleep apnea & airway implants | 7 | 262+60%/yr | +60%/yr | 0.21.1× | 0% | 230 in 2030−2.4%/yr |
| Cochlear implants | 4 | 209+11%/yr | +11%/yr | 0.21.0× | 0% | 320 in 2030+7.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 133 | 7,179−2.5%/yr | −2.5%/yr | 7.01.0× | 2% | 6,960 in 2030−0.5%/yr |
| Tumor & fibroid embolization | 7 | 370+1.9%/yr | +1.9%/yr | 0.30.6× | 67% | 1,280 in 2030+23%/yr |
| Tumor ablation | 1 | 253−4.9%/yr | −4.9%/yr | 0.20.7× | 0% | 520 in 2030+13%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 278 | 30,536+34%/yr | +34%/yr | 27.11.0× | 66% | 55,500 in 2030+10%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Pacemaker, ICD & CRT implantation | 116 | 5,350−4.9%/yr | −4.9%/yr | 5.00.9× | 0% | 5,520 in 2030+0.5%/yr |
| EP ablation | 100 | 4,592+3.6%/yr | +3.6%/yr | 3.41.1× | 0% | 7,400 in 2030+8.3%/yr |
| LAA occlusion & loop recorders | 94 | 3,603+4.6%/yr | +4.6%/yr | 2.80.9× | 1% | 6,180 in 2030+9.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 211 | 8,829−5.6%/yr | −5.6%/yr | 6.41.1× | 0% | 9,250 in 2030+0.8%/yr |
| Structural heart (TAVR, TEER) | 99 | 2,063+1.4%/yr | +1.4%/yr | 1.50.8× | 0% | 2,940 in 2030+6.1%/yr |
| Mechanical circulatory support | 4 | 698−2.7%/yr | −2.7%/yr | 0.61.0× | 0% | 770 in 2030+1.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Aneurysm & intracranial embolization | 15 | 485+7.7%/yr | +7.7%/yr | 0.41.0× | 0% | 720 in 2030+6.9%/yr |
| Stroke thrombectomy | 16 | 453−0.3%/yr | −0.3%/yr | 0.41.0× | 0% | 410 in 2030−1.6%/yr |
| DBS & VNS | 9 | 430−6.8%/yr | −6.8%/yr | 0.41.1× | 0% | 580 in 2030+5.2%/yr |
| CSF shunts | 5 | 266−5.3%/yr | −5.3%/yr | 0.21.3× | 0% | 270 in 2030+0.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 292 | 74,196−1.5%/yr | −1.5%/yr | 65.81.0× | 76% | 79,700 in 2030+1.2%/yr |
| Vitreoretinal surgery | 51 | 3,204−1.9%/yr | −1.9%/yr | 2.91.3× | 78% | 3,460 in 2030+1.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 759 | 134,256−3.1%/yr | −3.1%/yr | 126.71.1× | 38% | 138,100 in 2030+0.5%/yr |
| Bronchoscopy & lung nodule | 65 | 3,959+2.2%/yr | +2.2%/yr | 3.61.0× | 0% | 6,330 in 2030+8.1%/yr |
| ERCP & endoscopic ultrasound | 60 | 3,607−1.1%/yr | −1.1%/yr | 3.30.8× | 1% | 4,620 in 2030+4.2%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.